Canon Medical Launches CT Solution to Quickly and Safely Image Patients With Viral Infectious Diseases

Deployable CT Solutions + Rapid Decontamination Can Help Hospitals Isolate Patients and Decontaminate the System for More Effective Care

In today’s challenging healthcare environment, radiology departments are often faced with the difficult decision of how to safely image patients who are suspected of being positive with infectious disease.

To help hospitals and institutions effectively utilize CT with these conditions, Canon Medical Systems USA, Inc. introduces a deployable CT with a rapid decontamination solution. The deployable system includes the Aquilion™ Prime SP CT system in a modular or mobile footprint with a rapid decontamination tool, to help isolate and decontaminate the CT for rapid, safe imaging.

The Aquilion Prime SP CT system offers complete clinical capability, with advanced imaging technology from Canon Medical’s high-end CT systems with the right balance between image quality and lower dose for every patient. The system can generate 160 unique slices per rotation with 0.35-second scanning, reducing time required to perform studies for compromised patients, and also increase throughput. With a 78-cm aperture gantry and a 660-pound patient-weight-capacity couch, the system is ideal for use in an emergency setting. The Aquilion Prime SP is now also available with Advanced Intelligent Clear-IQ Engine (AiCE) Deep Learning Reconstruction (DLR), enabling clinicians to enhance diagnostic confidence at low doses. Now available in a modular or mobile setup for easy deployment, the system can be isolated from other facility staff and patients, providing a safer environment for imaging patients suspected to have infectious diseases.

The decontamination system is an automated UV-C technology that significantly reduces bacteria, spores and viruses and is effective against a variety of advanced viral infectious diseases. The system incorporates multiple automated UV-C emitters that work together to provide decontamination of the room in minutes to help improve workflow. The decontamination system is available for the new deployable CT solutions, as well as existing fixed imaging suites.

“Imaging infectious disease patients is not a new phenomenon for medical providers. But our customers are facing an unprecedented number of potentially contagious patients,” said Erin Angel, managing director, CT Business Unit, Canon Medical Systems USA, Inc. “Our deployable CT offerings with the addition of rapid UV-C decontamination will offer providers a unique solution to help improve their workflow and safety as they image infectious disease patients.”

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Carestream Health notes twenty-seven of the patents were awarded by the U.S. Patent and Trademark Office; an additional 43 patents were received in European and Asian countries.
According to an Insightec study, patients experienced significant reductions in upper limb tremor, tremor-related disability, and quality of life. The most common intraprocedural adverse events included dizziness, headache, nausea, and vomiting, which all resolved. Post-procedural adverse events included paraesthesia and gait disturbance, which were often transient or resolved within 12 months.
Chris Landon, Business Leader Image Guided Therapy Devices at Philips: “IVUS is a technology that has demonstrated an ability to both support safer procedures for patients and procedural staff alike including reductions in radiation exposure. As the global leader in IVUS solutions, we are grateful for the rigorous multidisciplinary approach to developing expert consensus on the value of IVUS and we look forward to working with all stakeholders to standardize the use of IVUS and reduce the barriers preventing utilization.”
"We are delighted to see our 3D solution CE-marked and available on the European market," says Ulrik Harrysson, CEO at SyntheticMR AB. "SyMRI 3D represents the next generation of quantitative MRI, offering unprecedented resolution and accuracy in brain imaging, revolutionizing the landscape of medical diagnostics."
Adrian Mendes, Perimeter's Chief Executive Officer, stated, "We believe this additional commercial placement within a major national healthcare system – representing the fifth unit placed with this existing customer network – demonstrates that surgeon end users, as well as other stakeholders within the broader healthcare system, see the value of our technology and are recommending it to their peers. Our aim is to make Perimeter's innovative technology the standard of care in cancer surgery."

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version